Molecular mapping of uncharacteristically small 5q deletions in two patients with the 5q- syndrome: delineation of the critical region on 5q and identification of a 5q- breakpoint.

Molecular mapping of uncharacteristically small 5q deletions in two patients with the 5q- syndrome: delineation of the critical region on 5q and identification of a 5q- breakpoint.

Molecular mapping techniques have defined the region of gene loss in two patients with the 5q- syndrome and uncharacteristically small 5q deletions (5q31-q33). The allelic loss of 10 genes localized to 5q23-qter (centromere-CSF2-EGR1-FGFA-GRL-ADRB2-CS F1R-SPARC-GLUH1-NKSF1-FLT4-telomere) was investi...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Boultwood, J, Fidler, C, Lewis, S, Kelly, S, Sheridan, H, Littlewood, T, Buckle, V, Wainscoat, J
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	1994

Gelijkaardige items

MOLECULAR MAPPING OF UNCHARACTERISTICALLY SMALL 5Q DELETIONS IN 2 PATIENTS WITH THE 5Q- SYNDROME - DELINEATION OF THE CRITICAL REGION ON 5Q AND IDENTIFICATION OF A 5Q- BREAKPOINT
door: Boultwood, J, et al.
Gepubliceerd in: (1993)

MOLECULAR DELINEATION OF THE CRITICAL REGION OF THE 5Q-CHROMOSOME IN THE 5Q-SYNDROME
door: Boultwood, J, et al.
Gepubliceerd in: (1993)

Molecular cytogenetic delineation of the critical deleted region in the 5q- syndrome.
door: Jaju, R, et al.
Gepubliceerd in: (1998)

Narrowing the critical deleted region in the 5q-syndrome.
door: Jaju, R, et al.
Gepubliceerd in: (1996)

The 5q-syndrome.
door: Boultwood, J, et al.
Gepubliceerd in: (1994)

5q- syndrome.
door: Boultwood, J, et al.
Gepubliceerd in: (2012)

Homozygous deletion of FMS in a patient with the 5q- syndrome.
door: Boultwood, J, et al.
Gepubliceerd in: (1990)

The 5q- syndrome.
door: Giagounidis, A, et al.
Gepubliceerd in: (2004)

ISOLATION OF NOVEL CDNA CLONES MAPPING TO THE CRITICAL REGION OF THE 5Q-CHROMOSOME IN THE 5Q-SYNDROME
door: Boultwood, J, et al.
Gepubliceerd in: (1994)

Advances in the 5q- syndrome.
door: Boultwood, J, et al.
Gepubliceerd in: (2010)

Allelic loss of IRF1 in myelodysplasia and acute myeloid leukemia: retention of IRF1 on the 5q- chromosome in some patients with the 5q- syndrome.
door: Boultwood, J, et al.
Gepubliceerd in: (1993)

Narrowing and genomic annotation of the commonly deleted region of the 5q- syndrome.
door: Boultwood, J, et al.
Gepubliceerd in: (2002)

Narrowing and genomic annotation of the critical region of the 5q-syndrome.
door: Boultwood, J, et al.
Gepubliceerd in: (2000)

Hematological features of patients with myelodysplastic syndromes associated with a chromosome 5q deletion.
door: Lewis, S, et al.
Gepubliceerd in: (1995)

The human POP2 gene: identification, sequencing, and mapping to the critical region of the 5q- syndrome.
door: Fidler, C, et al.
Gepubliceerd in: (1999)

Molecular analysis of the 5q-syndrome
door: Boultwood, J
Gepubliceerd in: (2007)

Primary transcription map of the critical region of the 5q-syndrome.
door: Boultwood, J, et al.
Gepubliceerd in: (1996)

MOLECULAR MAPPING OF THE 7Q-DELETION IN MYELOID DISORDERS
door: Lewis, S, et al.
Gepubliceerd in: (1993)

Novel genes mapping to the critical region of the 5q- syndrome.
door: Boultwood, J, et al.
Gepubliceerd in: (1997)

Mutation analysis of the SPARC gene in the 5q-syndrome.
door: Fidler, C, et al.
Gepubliceerd in: (2000)

Physical mapping of the human ATX1 homologue (HAH1) to the critical region of the 5q- syndrome within 5q32, and immediately adjacent to the SPARC gene.
door: Boultwood, J, et al.
Gepubliceerd in: (2000)

Molecular diagnosis of the 5q deletion in malignant myeloid disorders.
door: Boultwood, J
Gepubliceerd in: (1996)

Gene expression profiling in 5q-syndrome and myelodysplastic syndromes.
door: Pellagatti, A, et al.
Gepubliceerd in: (2003)

Lineage studies of 5q deletions using combined immunophenotyping and fish.
door: Jaju, R, et al.
Gepubliceerd in: (1999)

NRAS, FLT3 and TP53 mutations in patients with myelodysplastic syndrome and a del(5q).
door: Fidler, C, et al.
Gepubliceerd in: (2004)

Isolation and analysis of novel genes mapping to the critical region of the 5q-syndrome
door: Fidler, C, et al.
Gepubliceerd in: (1998)

Isolation and analysis of novel candidate genes mapping to the critical region of the 5q-syndrome.
door: Boultwood, J, et al.
Gepubliceerd in: (1999)

Combined immunophenotyping and FISH identifies the involvement of B-cells in 5q- syndrome.
door: Jaju, R, et al.
Gepubliceerd in: (2000)

A new recurrent translocation, t(5;11)(q35;p15.5), associated with del(5q) in childhood AML.
door: Jaju, R, et al.
Gepubliceerd in: (1998)

Molecular characterization of the 7q deletion in myeloid disorders.
door: Lewis, S, et al.
Gepubliceerd in: (1996)

Gene expression profiling of CD34+ cells in patients with the 5q- syndrome.
door: Boultwood, J, et al.
Gepubliceerd in: (2007)

Lenalidomide selectively inhibits in vitro growth of the malignant clone in myelodysplastic syndrome (MDS) patients with 5q deletion.
door: Jadersten, M, et al.
Gepubliceerd in: (2005)

Combined immunophenotyping and FISH for identification of cell lineages with the 5q-abnormality
door: Jaju, R, et al.
Gepubliceerd in: (1999)

Haploinsufficiency of ribosomal proteins and p53 activation in anemia: Diamond-Blackfan anemia and the 5q- syndrome.
door: Boultwood, J, et al.
Gepubliceerd in: (2012)

Pathophysiologic and clinical implications of molecular profiles resultant from deletion 5q
door: Adema, V, et al.
Gepubliceerd in: (2022)

Haploinsufficiency of RPS14 in 5q- syndrome is associated with deregulation of ribosomal- and translation-related genes.
door: Pellagatti, A, et al.
Gepubliceerd in: (2008)

Lenalidomide up-regulates SPARC and inhibits in vitro growth of the malignant clone in myelodysplastic syndrome patients with 5q deletion.
door: Pellagatti, A, et al.
Gepubliceerd in: (2006)

Gene expression profiling in patients with myelodysplastic syndromes, including patients with the del(5q)
door: Boultwood, J
Gepubliceerd in: (2009)

Expression profiling of CD34+cells in patients with myelodysplastic syndromes with and without a del(5q).
door: Pellagatti, A, et al.
Gepubliceerd in: (2004)

Activation of the mTOR pathway by the amino acid (L)-leucine in the 5q- syndrome and other ribosomopathies.
door: Boultwood, J, et al.
Gepubliceerd in: (2013)